Overview

Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients with Open-angle Glaucoma or Ocular Hypertension

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The main purpose is to compare the ocular hypotensive efficacy and safety of two concentrations of T4090 (Kinezodianone R HCl 0.2% and 0.3%) ophthalmic solution with Rhopressa® ophthalmic solution
Phase:
PHASE2
Details
Lead Sponsor:
Laboratoires Thea